Migraine & Charles Bonnet Syndrome

Overview

Migraine visual aura and Charles Bonnet syndrome are often discussed together because they share a single unsettling feature: the patient sees something that isn't actually in front of them. Beyond that surface similarity, the two conditions have almost nothing in common. They arise from different mechanisms, occur in visual systems in completely different states of health, produce different kinds of imagery, and carry entirely different clinical implications.

Migraine aura is a transient, self-limited phenomenon that occurs in a patient whose visual pathways are otherwise structurally normal — it's a temporary electrical disturbance, not a sign of eye disease. Charles Bonnet syndrome, by contrast, is a marker of significant, established vision loss. It doesn't happen to people with normal sight; it happens specifically because the visual system has lost a substantial amount of its normal input.

The reason this distinction matters clinically is less about the visual symptom itself and more about what each one implies for the patient in front of you. A patient describing migraine aura usually needs migraine management, if anything at all. A patient describing Charles Bonnet hallucinations needs something different and, in a way, more urgent: reassurance that what they're experiencing does not mean they are losing their mind, plus attention to the underlying eye disease that caused their vision loss in the first place. Recognizing which condition is actually being described is the entire clinical task.

Clinical Features

Migraine Visual Aura

The classic migraine aura is a scintillating scotoma: a shimmering, zigzag pattern of light that begins near fixation and slowly expands outward across the visual field over the course of the episode. Its jagged, angular shape has given it a second, more descriptive name — the fortification spectrum (or fortification scotoma) — because the zigzag border resembles the angled bastion walls of a star-shaped fort as seen from above.

Mechanistically, the aura is thought to result from cortical spreading depression: a slow-moving wave of neuronal and glial depolarization that travels across the occipital cortex, followed by a wave of suppressed activity. As that wave moves across the visual cortex, it generates the characteristic expanding, moving pattern of the scotoma, correlating with the aura's gradual growth and migration across the visual field over minutes.

Critically, this is a positive visual phenomenon — something is seen that isn't actually there — occurring in a patient whose eyes, optic nerves, and visual pathways are structurally normal. The aura classically precedes or accompanies the headache phase of a migraine, though it can also occur in isolation, without headache at all (acephalgic migraine).

Charles Bonnet Syndrome

Charles Bonnet syndrome produces a very different kind of visual experience: complex, formed visual hallucinations — people, faces, animals, patterns, or detailed scenes — rather than the simple geometric shimmer of a migraine aura. It occurs in patients who are cognitively intact but have significant, acquired vision loss, most commonly from conditions like age-related macular degeneration or advanced glaucoma, though any cause of substantial (but not necessarily total) vision loss can produce it.

The leading explanation is cortical deafferentation: when the visual cortex is chronically deprived of its normal sensory input, it can begin generating spontaneous, complex imagery on its own — analogous to how other sensory cortices can generate phantom sensations when deprived of their usual input. The hallucinations are purely visual; they aren't accompanied by hallucinations in other senses, and they don't interact with the patient or respond to anything the patient does.

The single most important clinical feature of Charles Bonnet syndrome is that patients typically retain insight that what they're seeing isn't real. They know the people or scenes aren't actually there, even while the images appear vivid and detailed. That preserved insight is what separates Charles Bonnet syndrome from a psychiatric or neurodegenerative hallucinatory disorder, where insight is often impaired or absent.

Migraine Aura vs. Charles Bonnet Syndrome

Laid side by side, the two conditions diverge on nearly every axis that matters clinically:

• Visual system status: Migraine aura occurs with a normal, structurally intact visual system. Charles Bonnet syndrome requires significant, established acquired vision loss.
• Mechanism: Migraine aura arises from cortical spreading depression moving across the occipital cortex. Charles Bonnet syndrome arises from cortical deafferentation — spontaneous cortical activity filling the gap left by lost visual input.
• Typical content: Migraine aura is simple and geometric — a zigzag, expanding fortification spectrum. Charles Bonnet hallucinations are complex and formed — people, faces, scenes, patterns.
• Duration and course: Migraine aura lasts on the order of minutes and then resolves completely, typically followed by (or accompanying) headache. Charles Bonnet syndrome is recurrent and often chronic, persisting as long as the underlying vision loss persists.
• Associated symptoms and cognition: Migraine aura is classically associated with headache (though it can occur without one). Charles Bonnet syndrome has no headache association, and cognition is entirely intact — this is not a dementia-related phenomenon.

Management

Migraine visual aura itself generally requires no ocular treatment — management is directed at the migraine as a whole (trigger avoidance, abortive or preventive therapy as indicated), not at the visual symptom in isolation, since the aura resolves on its own within the episode.

Charles Bonnet syndrome is managed primarily through reassurance. Because patients often fear they are developing a psychiatric illness or dementia, simply explaining the mechanism — that this is a well-recognized consequence of vision loss in a cognitively normal person, not a sign of mental illness — is frequently the most therapeutic intervention available. Beyond reassurance, management focuses on addressing the underlying cause of vision loss itself where possible, since the hallucinations are a downstream consequence of the visual deficit rather than a separate disease process to treat directly.

Related Topics

Continue exploring Systemic Disease & the Eye: